微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 41.12% | -5% | -1.82% | 42/54 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 41.88% | 1.35% | 0.3% | 43/54 | 68.65% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 41.75% | -2.68% | -0.13% | 43/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 41.81% | -0.83% | -3.4% | 43/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 43.28% | 3.68% | 4.74% | 42/54 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 41.32% | 14.56% | -3.69% | 41/54 | 68.3% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 42.9% | 5.12% | 1.77% | 40/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 42.16% | -5.41% | 0.99% | 42/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 41.74% | -2.79% | 15.73% | 42/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 36.07% | -11.76% | -11.63% | 43/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 40.81% | 0.23% | -8.42% | 42/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 44.57% | 10.08% | 3.79% | 41/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 42.94% | 5.19% | 5.05% | 37/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 40.87% | 9.93% | 0.38% | 45/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 40.72% | 9.83% | 0.58% | 42/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 40.48% | 12.12% | -0.82% | 43/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 40.82% | 28.31% | 9.78% | 35/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 37.18% | -3.14% | 0.29% | 44/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 37.07% | 0.25% | 2.67% | 34/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 36.11% | 3.31% | 13.5% | 41/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 31.81% | -6.17% | -17.12% | 31/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 38.39% | -3.49% | 3.8% | 40/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 36.98% | -12.66% | 5.81% | 26/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 34.95% | -16.22% | 3.08% | 26/54 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 33.91% | -15.11% | -14.75% | 23/54 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 39.77% | -10.24% | -6.07% | 35/54 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 42.34% | -7.81% | 1.49% | 22/54 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 41.72% | -5.08% | 4.45% | 23/54 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 39.94% | 2% | -9.85% | 20/54 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 44.31% | -6.5% | -3.53% | 32/54 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 45.93% | 2% | 4.49% | 20/54 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 43.95% | -2.89% | -7.25% | 22/54 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2016-12-31 | 47.39% | 1.92% | 1.92% | 26/54 | 68.41% | 我武生物 | 97.16% | 行业排名> |
| 2015-12-31 | 46.5% | 4.88% | 2.73% | 24/54 | 65.23% | 欧林生物 | 99.46% | 行业排名> |
| 2015-06-30 | 45.26% | 2% | 2.09% | 18/54 | 61.38% | 我武生物 | 95.96% | 行业排名> |